IBSA at the EULAR Congress, London, June 2016

IBSA at the EULAR Congress, London, June 2016

The European League Against Rheumatism is one of the most relevant congresses in the world of rheumatology.

As a leading company in this field, IBSA will participate with a Satellite Symposium entirely focusing on our highly purified, pharmaceutical-grade chondroitin sulfate; in particular, very interesting data of the new clinical study (CONCEPT study) comparing chondroitin sulfate vs celebrex and vs placebo will be presented. See the full programme here.

All people interested in knowing more about IBSA as leading Company in the field of OA and Pain, and about its pipeline of products (Condrosulf/chondroitin sulphate; Sinovial/i.a. HA; Flector/diclofenac epolamine; Akis-Dicloin/subcutaneous diclofenac) are also invited to visit us in the exhibition hall (stand #900, Hall S12).
Watch videos of IBSA Satellite Symposium here

Published on

2016 © IBSA Institut Biochimque SA - All rights reserved

This website uses cookies to help us give you the best experience when you visit. By using this website you consent to our use of these cookies. Find out more about how we use cookies and how to manage them by reading our cookie notice. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.